Topamax Shortage Update: What Patients Need to Know in 2026

If you've searched online for "Topamax shortage 2026" or asked your pharmacist why they don't have your prescription ready, you deserve a straight answer. This post gives you the most current information available on topiramate availability in the United States — what's happening, what's not happening, and what it means for you.

Current Topiramate Shortage Status (2026)

As of 2026, generic topiramate is NOT on the FDA Drug Shortage Database as an active nationwide shortage in the United States. Topiramate has been off-patent since approximately 2006, and multiple FDA-approved manufacturers currently produce it. The generic market is mature and competitive, which keeps prices low and supply generally stable.

However, patients across the country continue to report difficulty filling prescriptions — especially for certain strengths (100 mg, 200 mg) or formulations (extended-release, oral solution). That gap between "no national shortage" and "can't fill my prescription" is real and frustrating.

Why Are Some Patients Still Having Trouble Finding Topamax?

Several factors contribute to localized availability gaps even when no formal shortage exists:

Manufacturer-specific disruptions: A single generic manufacturer experiencing a production delay affects the pharmacies that source from them. Other manufacturers may be shipping normally, but your local pharmacy may only carry one brand of generic.

Formulation-specific scarcity: Extended-release versions (Qudexy XR, Trokendi XR) and the oral liquid (Eprontia) are stocked by far fewer pharmacies than standard immediate-release tablets. If your prescription calls for one of these, you'll need to search more broadly.

UK shortage news creating confusion: In recent years, the UK has experienced topiramate supply issues from Janssen (the original brand manufacturer). U.S. patients sometimes see these reports and worry about domestic availability — but U.S. and UK pharmaceutical supply chains are separate.

High-dose prescriptions: Most pharmacy inventory is focused on the most commonly prescribed doses (25 mg and 50 mg). Pharmacies in smaller markets may not stock 100 mg or 200 mg tablets routinely.

Historical Context: Has Topamax Ever Been in Shortage?

Topamax was originally approved by the FDA on December 24, 1996, for Janssen Pharmaceuticals. After the patent expired (around 2006), Mylan Pharmaceuticals was among the first to receive FDA approval for generic topiramate, and the generic became commercially available in September 2006. Since then, multiple generics entered the market, and the U.S. has not experienced a prolonged nationwide topiramate shortage.

The most notable shortage history has been in the United Kingdom, where Janssen-supplied Topamax brand has occasionally experienced supply issues, prompting emergency ordering protocols for UK pharmacies.

What Should You Do If You Can't Find Topamax?

Don't stop taking your medication. Contact your prescriber before running out.

Call multiple pharmacies. Availability varies significantly from one location to the next, even within the same city.

Use medfinder. medfinder calls pharmacies near you to check which ones have your prescription available, saving you time.

Ask your pharmacy to order it. Most pharmacies can receive an order within 1-2 business days.

Consider a mail-order pharmacy for your next 90-day refill.

Price Outlook for Topiramate in 2026

Generic topiramate is one of the most affordable anticonvulsants on the market. Retail prices for a 30-day supply of 25 mg or 50 mg tablets typically range from $6–$35, depending on the pharmacy. With a GoodRx coupon, many patients pay as little as $1.80–$5 for a 30-day supply of generic topiramate. Extended-release formulations are significantly more expensive ($140–$600 per month without discounts).

Prices are expected to remain stable in 2026, with supply continuing to be driven by multiple competing generic manufacturers. Significant price increases are unlikely given the fully commoditized generic market.

The Bottom Line for Topamax Patients in 2026

There is no active nationwide topiramate shortage in the U.S. as of 2026. Most patients who are having trouble filling their prescription are dealing with localized inventory gaps or formulation-specific issues — not a true supply crisis. If you're struggling to get your prescription, medfinder can help locate nearby pharmacies that have it in stock.

If you've exhausted nearby options, learn what's available: Alternatives to Topamax If You Can't Fill Your Prescription.